FDA Panel Endorses Class II Status for Surgical Mesh Instrumentation
This article was originally published in The Gray Sheet
Executive Summary
The Gastroenterology and Urology Devices Panel supported FDA’s proposal to up-classify surgical mesh instrumentation from class I to class II with special controls.
You may also be interested in...
FDA Moves Mesh Surgical Instrumentation Up To Class II In Final Order
The US agency has agreed with an earlier assessment by an advisory panel last year to up-classify surgical mesh instrumentation by issuing a Jan. 6 final order to move the instrumentation – used for women undergoing pelvic organ prolapse or female stress incontinence procedures – from class I to class II.
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.